BSE filing, NSE: TIRFOAM. Summary written from the filing by ALFA Finder's alert engine.
Tirupati Foam Ltd: key numbers
- Share price
- ₹68.00
- Market cap
- ₹29.97 Cr
- Revenue (annual)
- ₹95.01 Cr
- Net profit (annual)
- ₹1.92 Cr
- P/E (TTM)
- 13.8×Sector 34.0×
- Promoter holding
- 70.04%-1.68% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tirupati Foam Ltd
All →Tirupati Foam Promoter Selling
Promoter Kalpesh Babulal Kothari sold 7,712 shares (0.17% stake) of Tirupati Foam Limited via open market transactions.
- Promoter stake change
- -0.17%
Tirupati Foam Promoter Selling
Tirupati Foam promoter group's Kalpesh B Kothari sold 13,717 equity shares (0.311%) in the open market. His stake fell from 1.535% to 1.224%.
Tirupati Foam Promoter Selling
Promoter Kalpesh B Kothari sold 21 Tirupati Foam shares in the open market on 8 Sept 2026. His stake fell marginally from 1.536% to 1.535%.
Tirupati Foam Annual General Meeting
Tirupati Foam Ltd held its 39th Annual General Meeting on 20th August 2026. Shareholders considered agenda items including dividend approval and disposal of Noida assets.
Tirupati Foam Q1 FY27 Results: Net Profit ₹0.7 Cr, Up 75.0% YoY
Tirupati Foam Ltd reported revenue from operations of ₹28.1 Cr (+22.2% YoY) and net profit of ₹0.7 Cr (+75.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.7 Cr · +75.0% YoY
Tirupati Foam Board Meeting Date
Tirupati Foam Limited has scheduled a board meeting on 12 August 2026 to consider and approve the standalone unaudited financial results for the quarter ended June 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.